日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Structure over color: Diagnostic information in H&E images resides primarily in grayscale

结构重于色彩:H&E图像中的诊断信息主要存在于灰度图像中。

Dalton, Leslie; Ellis, Ian O; Rakha, Emad A

Expression of the zinc-finger transcription factor Osterix (SP7) in invasive breast cancer and its prognostic significance.

锌指转录因子 Osterix (SP7) 在浸润性乳腺癌中的表达及其预后意义

Saidy Behnaz, Gull Laura, Hacker Andrew G, Rakha Emad A, Green Andrew R, Ellis Ian O, Martin Stewart G, Storr Sarah J

Malignant phyllodes tumours of the breast: the case for revising WHO's 'full house' diagnostic criteria

乳腺恶性叶状肿瘤:修订世卫组织“满堂红”诊断标准的必要性

Tan, Puay Hoon; Ellis, Ian O; Allison, Kimberly H; Badve, Sunil S; Brogi, Edi; Callagy, Grace; Charafe-Jauffret, Emmanuelle; Chen, Chih-Jung; Chen, Yunn-Yi; Collins, Laura C; Cserni, Gábor; Djerroudi, Lounes; Foschini, Maria Pia; Fox, Stephen B; Gobbi, Helenice; Gudi, Mihir; Harada, Oi; Jaffer, Shabnam; Kulka, Janina; Kuroda, Hajime; Lakhani, Sunil R; Li, Xiaoxian; Moriya, Takuya; O'Toole, Sandra; Pinder, Sarah E; Provenzano, Elena; Quinn, Cecily; Raymond, Wendy; Sahin, Aysegul A; Schmitt, Fernando; Shaaban, Abeer M; Shet, Tanuja; Siziopikou, Kalliopi P; Tang, Ping; Tse, Gary M; Varga, Zsuzsanna; Vincent-Salomon, Anne; Wen, Hannah; Yamaguchi, Rin; Yang, Wentao; Schnitt, Stuart J; Rakha, Emad A

SLC1A5 is a key regulator of glutamine metabolism and a prognostic marker for aggressive luminal breast cancer.

SLC1A5 是谷氨酰胺代谢的关键调节因子,也是侵袭性管腔型乳腺癌的预后标志物

Alfarsi Lutfi H, Ansari Rokaya El, Erkan Busra, Fakroun Ali, Craze Madeleine L, Aleskandarany Mohammed A, Cheng Kiu Wai, Ellis Ian O, Rakha Emad A, Green Andrew R

What factors influence cellular pathologists' confidence in case reporting?

哪些因素会影响细胞病理学家对病例报告的信心?

Evans, Harriet; Kimani, Peter K; Hiller, Louise; Tsang, Yee Wah; Sah, Shatrughan; Gopalakrishnan, Kishore; Boyd, Clinton; Loughrey, Maurice B; Kelly, Paul J; Boyle, David P; Clark, David; Ellis, Ian O; Ilyas, Mohammad; Rakha, Emad; Bickers, Adam; Roberts, Ian S D; Soares, Maria F; Neil, Desley A H; Dunn, Janet A; Azam, Ayesha; Snead, David

Hydroxyacid Oxidase 1, a Glutamine Metabolism-Associated Protein, Predicts Poor Patient Outcome in Luminal Breast Cancer.

羟基酸氧化酶 1 是一种与谷氨酰胺代谢相关的蛋白质,可预测管腔型乳腺癌患者的不良预后

Erkan Busra, MacIntyre Skye, Brown Charlotte, Fakroun Ali, Lashen Ayat G, Mongan Nigel P, Ellis Ian O, Rakha Emad A, Green Andrew R

ATF4 as a Prognostic Marker and Modulator of Glutamine Metabolism in Oestrogen Receptor-Positive Breast Cancer.

ATF4 作为雌激素受体阳性乳腺癌的预后标志物和谷氨酰胺代谢调节因子

Patel Roshni, Alfarsi Lutfi H, El-Ansari Rokaya, Masisi Brendah K, Erkan Busra, Fakroun Ali, Ellis Ian O, Rakha Emad A, Green Andrew R

Cell cycle traverse rate predicts long-term outcomes in a multi-institutional cohort of patients with triple-negative breast cancer

细胞周期进程率可预测三阴性乳腺癌多中心患者队列的长期预后

Bhattarai, Shristi; Rupji, Manali; Chao, Hsueh-Ping; Xu, Qi; Saini, Geetanjali; Rida, Padmashree; Aleskandarany, Mohammed A; Green, Andrew R; Ellis, Ian O; Janssen, Emiel A; Jonsdottir, Kristin; Rakha, Emad; Kowalski, Jeanne; Aneja, Ritu

A retrospective analysis of ezrin protein and mRNA expression in breast cancer: Ezrin expression is associated with patient survival and survival of patients with receptor-positive disease

对乳腺癌中ezrin蛋白和mRNA表达的回顾性分析:Ezrin表达与患者生存率以及受体阳性患者的生存率相关

Storr, Sarah J; Hoskin, Victoria; Aiyappa-Maudsley, Radhika; Ghaffari, Abdi; Varma, Sonal; Green, Andrew; Rakha, Emad; Ellis, Ian O; Greer, Peter A; Martin, Stewart G

Impact of COVID-19 on the practice of breast pathologists: a survey of breast pathologists in the UK and Ireland

新冠疫情对乳腺病理学家执业的影响:一项针对英国和爱尔兰乳腺病理学家的调查

Elghobashy, Mirna; Wahab, Lutful; Gunavardhan, Anu; O'Sullivan, Emma; Provenzano, Elena; Deb, Rahul; Pritchard, Susan; Di Palma, Silvana; Ellis, Ian O; Boyd, Clinton; Pinder, Sarah E; Shaaban, Abeer M